Hormonal changes induced by changing amounts of protein and phosphorus in the diet of healthy volunteers

ISRCTN ISRCTN10876564
DOI https://doi.org/10.1186/ISRCTN10876564
Protocol serial number 2008/155
Sponsor Vrije University Medical Centre (VUMC) (Netherlands)
Funder Vrije University Medical Centre (VUMC) (Netherlands) - Departments of nephrology and biochemistry
Submission date
06/05/2010
Registration date
27/05/2010
Last edited
30/08/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Marc Vervloet
Scientific

De Boelelaan 1117
Amsterdam
1081 HV
Netherlands

Phone 31-20-4442673
Email m.vervloet@vumc.nl

Study information

Primary study designInterventional
Study designNon-randomised controlled crossover group trial
Secondary study designNon randomised controlled trial
Study type Participant information sheet
Scientific titleEffects of changes in dietary phosphorus intake on fibroblast growth factor 23 (FGF23) levels in healthy volunteers: a controlled crossover trial
Study objectivesBackground:
This study is related to patients with kidney disease. Kidney disease, as defined by a decline in estimated Glomerular Filtration Rate (GFR), as even in early stages related to disturbances in the metabolism of minerals, especially calcium and phosphorus, and Fibroblast growth factor 23 (FGF23). The latter is related to clinical endpoints and mortality.

Hypothesis
Changes in phosphate intake lead to parallel changes in levels of FGF23, even in healthy volunteers. These changes in FGF23 in turn lead to increases in phosphaturia and changes in levels of 1,25 dihydroxyvitamin D, both independent from possible changes in PTH or serum phosphate levels.
Ethics approval(s)The local medical ethics committe (Medisch Ethische Toetsingscommissie) of Vrije University Medical Centre (VUMC) approved on the 11th of August 2008 (ref: 2008/155)
Health condition(s) or problem(s) studiedKidney disease
InterventionSubjects are switched from regular diet to phosphate-restricted diet for two days, and the back to regular diet for ten days. After that they are switched from regular diet to phopsphate-enriched diet and the back again. No other interventions are made.

Both the primary and secondary endpoint were determined during the interventional periods, because changes induced by the intervention are almost immediate.
Intervention typeOther
Primary outcome measure(s)

Changes in FGF23 levels, determined using sandwich ELISA for both C-terminal FGF23 (provided by Immutopics, San Clemente, USA) and Intact FGF23 (provided by Kainos, Japan).

Key secondary outcome measure(s)

1. Changes in phosphaturia
2. Changes in levels of metaboliotes of vitamin D (1,25 dihydroxyvitamin D)
Outcomes analysed by standard laboratory techniques and radio-immuno assay (IDS, Tyne and Wear, UK) respectively

Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration10
Key inclusion criteria1. Male or female
2. Non-smoking subjects
3. Normal renal function, as defined by estimated Glomerular Filtration Rate (GFR) above 80 ml/min.
4. Females should have a negative test for pregnancy at baseline
Key exclusion criteria1. Abnormal kidney function
2. Substantial comorbidity
Date of first enrolment01/08/2008
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

De Boelelaan 1117
Amsterdam
1081 HV
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes